advertisement

---

Prokosch-Willing V 13

Showing records 1 to 13 | Display all abstracts from Prokosch-Willing V

100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Thein AS
American Journal of Ophthalmology 2022; 241: 190-197

---

100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Gietzelt C; Lüke JN
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329

---

100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Hedengran A; Azuara-Blanco A
American Journal of Ophthalmology 2022; 241: 190-197

---

100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Adler W; Dietlein TS
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329

---

100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Arita R; Cvenkel B
American Journal of Ophthalmology 2022; 241: 190-197

---

100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Lappas A; Prokosch-Willing V
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329

---

100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Gazzard G; Heegaard S
American Journal of Ophthalmology 2022; 241: 190-197

---

100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Roters S
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329

---

100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
de Paiva CS
American Journal of Ophthalmology 2022; 241: 190-197

---

100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Heindl LM; Cursiefen C
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329

---

100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Petrovski G; Prokosch-Willing V
American Journal of Ophthalmology 2022; 241: 190-197

---

100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Enders P
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329

---

100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Utheim TP; Virgili G; Kolko M
American Journal of Ophthalmology 2022; 241: 190-197

---